We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · December 05, 2020

β-Blocker Use Improves Survival and Pulmonary Function in Patients With COPD and CVD

European Heart Journal


Additional Info

European Heart Journal
Association of β-Blocker Use With Survival and Pulmonary Function in Patients With Chronic Obstructive Pulmonary and Cardiovascular Disease: A Systematic Review and Meta-Analysis
Eur Heart J 2020 Nov 19;[EPub Ahead of Print], YL Yang, ZJ Xiang, JH Yang, WJ Wang, ZC Xu, RL Xiang

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading